Hidradenitis Suppurativa: all 280 studies

Page 1 of 3. Open to participants first (85), then studies with results posted, then the rest; newest registration first within each.

• A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HSRecruitingNCT07855276Phase 1
• Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or ObesityNot yet recruitingNCT07830329Phase 2
• Safety and Efficacy of Soquelitinib in Adults With Hidradenitis SuppurativaRecruitingNCT07828860Phase 1
• Urinary Bladder Matrix (UBM) RegistryNot yet recruitingNCT07805798
• Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin DiseasesNot yet recruitingNCT07804134
• Mediterranean Dietary Intervention for HSNot yet recruitingNCT07800416Not applicable
• ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaRecruitingNCT07783542Phase 2
• A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)RecruitingNCT07766005Phase 2
• Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis SuppurativaNot yet recruitingNCT07756346Phase 2
• Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRIRecruitingNCT07755670
• An Observational Study of Patients With Dermatologic DiseaseNot yet recruitingNCT07748169
• A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa PatientsNot yet recruitingNCT07690319
• Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis SuppurativaRecruitingNCT07689188Phase 2
• FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot StudyNot yet recruitingNCT07668713Phase 1
• An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSRecruitingNCT07665437Phase 3
• Global Healthcare Study on Hidradenitis SuppurativaRecruitingNCT07659769
• A Single-center, Prospective, Self-controlled, Observational Real-world Study of the Efficacy and Safety of Anti-IL-17A/F Monoclonal Antibody Combined With Non-ablative Dot Laser for the Treatment of Mild to Moderate Hidradenitis SuppurativaNot yet recruitingNCT07554014Phase 4
• A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis SuppurativaRecruitingNCT07547813Phase 2
• Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian PopulationRecruitingNCT07543419
• Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07489573Phase 4
• A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With SecukinumabNot yet recruitingNCT07454889
• Radiotherapy for Refractory Hidradenitis SuppurativaRecruitingNCT07414550Not applicable
• MAIT Cells in Hidradenitis SuppurativaNot yet recruitingNCT07388446Not applicable
• A Study to Assess NAV-240 in Adult Participants With Hidradenitis SuppurativaRecruitingNCT07384975Phase 2
• LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical PracticeNot yet recruitingNCT07336641
• Pelashield™ PainGuard™ vs Restrata® in HS SurgeryRecruitingNCT07316192Not applicable
• Real-world Secukinumab Outcomes in Canadian HS PatientsRecruitingNCT07282015
• The Safety and Efficacy of Roflumilast Foam in HSRecruitingNCT07263230Phase 2
• Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HSNot yet recruitingNCT07261072Phase 4
• Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07244510Phase 2
• A Study of Zasocitinib in Adults With Hidradenitis SuppurativaRecruitingNCT07244263Phase 2
• Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaRecruitingNCT07243782
• A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07225569Phase 2
• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07213973Phase 2
• Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07170917Phase 2
• 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)RecruitingNCT07155239Phase 1
• A Study of LAD191 in Adults With Hidradenitis SuppurativaRecruitingNCT07151937Phase 2
• A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis SuppurativaRecruitingNCT07136467
• A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) TherapeuticRecruitingNCT07123038
• Secukinumab Treatment for Moderate to Severe Hidradenitis SuppurativaRecruitingNCT07109765
• Neutralizing Interferon Type 1 in Hidradenitis SuppurativaNot yet recruitingNCT07067099Phase 1
• Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis SuppurativaRecruitingNCT07049575Phase 1
• SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaEnrolling by invitationNCT07007637Phase 3
• Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis SuppurativaNot yet recruitingNCT06960447Not applicable
• A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsRecruitingNCT06946641Phase 1
• A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis SuppurativaRecruitingNCT06932003Phase 1/2
• Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis SuppurativaRecruitingNCT06926192
• Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.RecruitingNCT06895499Phase 1/2
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)RecruitingNCT06888193Phase 1
• Rollover Study for Participants Previously Enrolled in Clinical Trials of PovorcitinibRecruitingNCT06855498Phase 3
• Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi ArabiaRecruitingNCT06785779
• HS ABSCESSES: I&D VS PUNCH DEBRIDEMENTNot yet recruitingNCT06731309Not applicable
• A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese PatientsRecruitingNCT06707246Not applicable
• Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%RecruitingNCT06645821Early Phase 1
• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesRecruitingNCT06599411
• A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabRecruitingNCT06524635Phase 2
• Pathophysiological Basis of Hidradenitis SuppurativaNot yet recruitingNCT06370052
• Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI)RecruitingNCT06368388
• Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.RecruitingNCT06326476Early Phase 1
• Defects of Keratinocytes Function in Dermatologic PatientsRecruitingNCT06324552
• Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis SuppurativaNot yet recruitingNCT06301256Not applicable
• A Journey Into Participation Patterns Among Patients With Hidradenitis SuppurativaNot yet recruitingNCT06201858
• The Living With a Long-Term Condition StudyRecruitingNCT06072287
• Capsule Microbiota Transplant Therapy for Hidradenitis SuppurativaRecruitingNCT06058520Early Phase 1
• Collection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersRecruitingNCT05994976
• Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis SuppurativaRecruitingNCT05934825Phase 1/2
• Determinants of Chronic Inflammatory Skin Disease TrajectoriesRecruitingNCT05928169
• Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa PatientsRecruitingNCT05821478Phase 3
• Efficacy of Laser Hair Removal Therapy in HSNot yet recruitingNCT05762484Not applicable
• Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT05635266
• Managed Access Programs for AIN457, SecukinumabAvailableNCT05583604
• Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis SuppurativaRecruitingNCT05531747Not applicable
• Regulation of Inflammatory Genes in Hidradenitis SuppurativaRecruitingNCT05507125
• A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa ExcisionsRecruitingNCT05477225Phase 4
• Targeting Nociceptors in Hidradenitis SuppurativaRecruitingNCT05403710
• Myriad™ Augmented Soft Tissue Reconstruction RegistryRecruitingNCT05243966
• Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic StrategyNot yet recruitingNCT05208099
• A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsEnrolling by invitationNCT05084417
• Intralesional Diode Laser Treatment of Fistulas in Hidradenitis SuppurativaRecruitingNCT04508374Not applicable
• Battlefield Acupuncture for Pain in Hidradenitis SuppurativaRecruitingNCT04218422Not applicable
• Expanded Access to UpadacitinibAvailableNCT04159597
• Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen RepositoryRecruitingNCT04115566
• Clinical and Biological Characteristics of Hidradenitis SuppurativaRecruitingNCT03967600
• The Ohio State University Dermatology BiorepositoryRecruitingNCT03146676
• A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With SpesolimabTerminatedNCT06241573Phase 2/3Results posted
• Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).TerminatedNCT05997277Phase 2Results posted
• Hidradenitis Suppurativa Study of IzokibepTerminatedNCT05905783Phase 3Results posted
• A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis SuppurativaCompletedNCT05849922Phase 2Results posted
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis SuppurativaCompletedNCT05819398Phase 2/3Results posted
• Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis SuppurativaCompletedNCT05635838Phase 2Results posted
• Hidradenitis Suppurativa Phase 2b Study of IzokibepCompletedNCT05355805Phase 2Results posted
• A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)TerminatedNCT05348681Phase 2Results posted
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis SuppurativaCompletedNCT05322473Phase 2Results posted
• ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)CompletedNCT05216224Phase 2Results posted
• Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa SurgeryCompletedNCT05194969Not applicableResults posted
• A Bioelectric Dressing for Post De-Roofing Treatment of HSCompletedNCT05057429Not applicableResults posted
• A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis SuppurativaTerminatedNCT04988308Phase 2Results posted
• A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical TrialCompletedNCT04876391Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis SuppurativaCompletedNCT04856930Phase 2Results posted

← Hidradenitis Suppurativa overview